The goal of Retro Biosciences – a biotechnology startup that has Sam Altman as its main financier – is to reverse the natural aging process and expand human life in ten years. California's company plans to combine several scientific methods – including changing the epigenetic editing mechanism (which activates and disables genes) and replacing old or sick cells with other leafy novelties – to make the body produce healthier cells within the dete…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The goal of Retro Biosciences – a biotechnology startup that has Sam Altman as its main financier – is to reverse the natural aging process and expand human life in ten years. California's company plans to combine several scientific methods – including changing the epigenetic editing mechanism (which activates and disables genes) and replacing old or sick cells with other leafy novelties – to make the body produce healthier cells within the dete…